Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ERNAWErnexa Therapeutics Inc.FY2024 · Dec |
|---|---|
| Revenue | $582.00K |
| Revenue, yoy | +755.9% |
| Net income | $14.08M |
| Net income, yoy | +68.4% |
| Net margin | — |
| Free cash flow | $7.05M |
| FCF margin | — |
| EPS, diluted | $2.24 |
Add another company.